Telehealth allows for clinical trial participation and multimodality therapy in a rural patient with stage 4 non-small cell lung cancer

James M. Clark, Laurence J. Heifetz, Daphne Palmer, Lisa M Brown, David T Cooke, Elizabeth David

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

Oligometastatic non-small cell lung cancer (NSCLC) has a poor prognosis for rural patients with traditional therapies. Implementation of multi-modality systemic therapy in conjunction with surgical resection can dramatically improve overall survival, leading to clinical complete remission. The currently accepted indications for resection in oligometastatic NSCLC include brain and adrenal metastases. Rural populations are known to have disparities in care of complex malignancies and the use of telehealth has been shown to improve outcomes. We present a case of a rural patient with stage IV NSCLC, who was able to participate in two clinical trials, undergo trimodality therapy, and remain disease-free for 18 months, whose care was facilitated via telehealth video conferencing with a tertiary care center.

Original languageEnglish (US)
Pages (from-to)139-142
Number of pages4
JournalCancer Treatment and Research Communications
Volume9
DOIs
StatePublished - Jan 1 2016

Keywords

  • Clinical trial
  • Non-small cell lung cancer (NSCLC)
  • Rural health
  • Telemedicine

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Telehealth allows for clinical trial participation and multimodality therapy in a rural patient with stage 4 non-small cell lung cancer'. Together they form a unique fingerprint.

  • Cite this